Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NINTEDANIB ESYLATE vs NITRAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NINTEDANIB ESYLATE vs NITRAZEPAM: Safety Overview

Metric NINTEDANIB ESYLATE NITRAZEPAM
Total FAERS Reports 117 1,165
Deaths Reported 23 365
Death Rate 19.7% 31.3%
Hospitalizations 39 466
Average Patient Age 66.4 yrs 51.2 yrs
% Female Patients 47.8% 54.1%
FDA Approval Date Oct 15, 2014 N/A
Manufacturer Boehringer Ingelheim Pharmaceuticals,... N/A
Route ORAL N/A
Marketing Status Prescription N/A